Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity
{{output}}
Therapeutically targeting pathogenic T cells in autoimmune diseases has been challenging. Although LAG-3, an inhibitory checkpoint receptor specifically expressed on activated T cells, is known to bind to major histocompatibility complex class II (MHC class II... ...
